Here’s Why Investors Liked AbbVie’s Q4 Results

1 min read

Shares of AbbVie (NYSE: ABBV) soared 21% in 2020, the stock’s best performance since 2017. The big pharma hasn’t gotten off to a great start so far in 2021, though, with shares down year to date. 

The beginning of a bounce could be underway now, however, for the Dividend Aristocrat. AbbVie announced positive fourth-quarter results before the market opened on Wednesday. Here are the highlights from the company’s update.

Image Source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Why Sonos Stock Popped to All-Time Highs

Next Story

Why Shares Rallied Nearly 17% Today

Latest from Blog